Mohammad Hossein Ahmadi | Skin inflammation | Editorial Board Member

Posted on by Skincare

Prof. Mohammad Hossein Ahmadi | Skin inflammation | Editorial Board Member

Associate Professor of Medical Bacteriology | Shahed University | Iran

Dr. Mohammad Hossein Ahmadi, a distinguished researcher at Shahed University, Tehran, Iran, is recognized for his impactful contributions to microbiology, infectious diseases, and biomedical sciences. He holds advanced academic training in biological and medical sciences, complemented by extensive research experience that spans cellular studies, antimicrobial resistance, and innovative therapeutic materials. Dr. Ahmadi’s research primarily focuses on antibacterial mechanisms, carbapenem-resistant pathogens, mesenchymal stem cell applications, wound-healing biomaterials, and clinical microbiology, positioning him at the forefront of efforts to address global challenges related to drug-resistant infections. Over his career, he has authored 28 peer-reviewed publications, which have collectively attracted over 297 citations, earning him an h-index of 9, reflecting both productivity and scholarly influence. His recent works—including studies on the antibacterial potential of BM-MSCs encapsulated in collagen–fibrin hydrogels and analyses of the global prevalence of carbapenem-resistant Pseudomonas aeruginosa—demonstrate his commitment to translational research with clear clinical and societal benefits. Dr. Ahmadi has collaborated with more than 50 international co-authors, highlighting his strong interdisciplinary and cross-institutional engagement. His research has contributed to advancing knowledge in infection control, biomaterials engineering, and public health, with widespread relevance to clinicians, biomedical researchers, and health-policy stakeholders. Although primarily dedicated to research, he also supports the scientific community through peer-review activities and participation in scholarly dissemination. Dr. Ahmadi’s work continues to influence emerging strategies for combating antibiotic-resistant infections and improving therapeutic outcomes, underscoring his role as an important contributor to global scientific progress.

Profiles: Scopus | ORCID | Google Scholar | Research Gate

Featured Publications

1. Ahmadi, M. H. (2021). Global status of tetracycline resistance among clinical isolates of Vibrio cholerae: A systematic review and meta-analysis. Antimicrobial Resistance & Infection Control.

2. Farzi, S., Rezazadeh, M., Mirhosseini, A., Rezazadeh, M. A., Houshyar, F., & Ahmadi, M. H. (2021). Genetic diversity of healthcare-associated methicillin-resistant Staphylococcus aureus isolates from Southern Iran. Acta Microbiologica et Immunologica Hungarica.

3. Ahmadi, M. H. (2021). Resistance to tetracyclines among clinical isolates of Mycoplasma hominis and Ureaplasma species: A systematic review and meta-analysis. Journal of Antimicrobial Chemotherapy.

4. Ahmadi, M. H. (2020). Indicated and non-indicated antibiotic administration during pregnancy and its effect on pregnancy outcomes: Role of inflammation. International Immunopharmacology.

5. Ahmadi, M. H. (2020). Frequency of antimicrobial resistance and class 1 and 2 integrons in Escherichia coli strains isolated from urinary tract infections. Iranian Journal of Pharmaceutical Research.

Rui Jiang | Skin Inflammation | Best Research Paper Award

Posted on by Skincare

Pro f. Rui Jiang | Skin Inflammation | Best Research Paper Award
Professor | Changchun University Of Chinese Medicine | China

Prof. Rui Jiang is an esteemed researcher at the Changchun University of Chinese Medicine, China, recognized for his groundbreaking work in natural product pharmacology, dermatological biochemistry, and inflammation research. He obtained his academic training in pharmaceutical and biochemical sciences, building a strong foundation in molecular mechanisms of bioactive natural compounds. With an impressive scholarly record of 47 publications, 852 citations, and an h-index of 16, Prof. Jiang has made significant contributions to understanding how herbal-derived molecules influence skin health, inflammation regulation, and cellular regeneration. His recent studies, such as on Glycyrrhiza glabra extract as a skin-whitening agent through CRTC1/MITF pathway modulation and Deoxyshikonin’s role in promoting hair growth via the Wnt/β-catenin signaling pathway, demonstrate his innovative integration of traditional medicine with modern molecular biology. His research also extends to the discovery of novel metabolites from endophytic fungi, contributing to the advancement of sustainable natural drug development. Prof. Jiang has collaborated with over 120 international co-authors, reflecting his active engagement in global scientific networks. He has received multiple institutional commendations for excellence in research and innovation and actively contributes to peer-review processes and editorial boards of pharmacology and dermatology journals. Through his dedication to evidence-based herbal medicine, Prof. Rui Jiang continues to bridge traditional wisdom with cutting-edge science, enhancing therapeutic approaches in skincare, inflammation control, and natural health innovation with broad societal impact.

Profile: Scopus

Publications

1. Jiang, R., et al. (2025). Research on the metabolites and biological activities of the endophytic fungus In ilyonectria cyclaminicola from Epimedium koreanum Nakai. Chemistry and Biodiversity.

2. Jiang, R., et al. (2025). Glycyrrhiza glabra extract as a skin-whitening agent: Identification of active components and CRTC1/MITF  pathway-inhibition mechanism. Journal of Ethnopharmacology.

3. Jiang, R., et al. (2025). Carbon nanodots derived from herbal extract ginsenoside Rg1 demonstrate highly effective inhibition against cervical carcinoma. Carbon Letters.

4. Jiang, R., et al. (2025). Deoxyshikonin from Arnebiae Radix promotes hair growth by targeting the Wnt/β-catenin signaling pathway. Phytomedicine.

 

Xin Li | Skin Inflammation | Best Research Paper Award

Posted on by Skincare

Prof. Xin Li | Skin Inflammation | Best Research Paper Award

Professor | Nanchang University | China

Prof. Xinu Li, currently serving at Nanchang University, China, is an accomplished researcher whose work bridges pharmaceutical sciences, biochemistry, and molecular medicine. Holding advanced degrees in biomedical and pharmaceutical research, Prof. Li has cultivated a distinguished academic record with 175 scientific publications, 3,138 citations, and an h-index of 31, underscoring the global influence and relevance of his research. His primary research areas encompass natural product chemistry, pharmacokinetics, skin biology, inflammation, and nanomedicine-based drug delivery systems. Prof. Li’s studies often focus on identifying bioactive compounds from herbal sources and elucidating their therapeutic mechanisms in dermatological and systemic diseases. He has collaborated extensively with over 290 international co-authors, contributing to interdisciplinary projects that merge traditional Chinese medicine with modern molecular biology and nanotechnology. His significant contributions have earned him recognition in leading journals, positioning him as a thought leader in natural pharmacology and skin research. Beyond his research achievements, Prof. Li actively participates in peer review and holds editorial roles in reputed international journals, promoting scientific excellence and innovation. His dedication to translational science and sustainable healthcare solutions continues to shape emerging paradigms in dermatological therapy and drug design. Prof. Li’s commitment to advancing evidence-based natural medicine exemplifies his broader impact on improving human health and fostering cross-cultural scientific collaboration on a global scale.

Profiles: Scopus | ORCID

Publications

1.  X., et al. (2025). Cleavage specificity of the pitcher fluid proteases from Nepenthes × miranda and their reduction on allergenicity of cow's milk proteins. Food Chemistry.
2. Li, X., et al. (2025). High-fat diet-induced obesity accelerates the progression of food allergy through synergistic effect of gut microbiota and lipid metabolism. Food Bioscience.
3. Li, X., et al. (2025). Interaction between Bacteroides and HG-type pectins with different molecular weights. International Journal of Biological Macromolecules.
4. Li, X., et al. (2025). 2′-FL in dairy matrices attenuates allergic symptoms in mice by reducing BLG hypersensitivity and modulating gut microecology. Journal of Agricultural and Food Chemistry.
5. Li, X., et al. (2025). Identification and validation of key amino acids in IgE linear epitopes of β-lactoglobulin: Comparison of recognition patterns of Chinese bovine milk-allergic sera with different symptoms. Journal of Agricultural and Food Chemistry.